Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
Hu Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, Liu Y, Schipani A, Davies G, Coates A. Hu Y, et al. Among authors: pertinez h. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4778-85. doi: 10.1128/AAC.02548-15. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27216065 Free PMC article.
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis.
Stott KE, Pertinez H, Sturkenboom MGG, Boeree MJ, Aarnoutse R, Ramachandran G, Requena-Méndez A, Peloquin C, Koegelenberg CFN, Alffenaar JWC, Ruslami R, Tostmann A, Swaminathan S, McIlleron H, Davies G. Stott KE, et al. Among authors: pertinez h. J Antimicrob Chemother. 2018 Sep 1;73(9):2305-2313. doi: 10.1093/jac/dky152. J Antimicrob Chemother. 2018. PMID: 29701775 Free PMC article.
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD. Velásquez GE, et al. Among authors: pertinez h. Am J Respir Crit Care Med. 2018 Sep 1;198(5):657-666. doi: 10.1164/rccm.201712-2524OC. Am J Respir Crit Care Med. 2018. PMID: 29954183 Free PMC article. Clinical Trial.
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis.
McCallum AD, Pertinez HE, Else LJ, Dilly-Penchala S, Chirambo AP, Sheha I, Chasweka M, Chitani A, Malamba RD, Meghji JZ, Gordon SB, Davies GR, Khoo SH, Sloan DJ, Mwandumba HC. McCallum AD, et al. Among authors: pertinez he. Clin Infect Dis. 2021 Nov 2;73(9):e3365-e3373. doi: 10.1093/cid/ciaa1265. Clin Infect Dis. 2021. PMID: 32856694 Free PMC article.
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis.
McCallum AD, Pertinez HE, Chirambo AP, Sheha I, Chasweka M, Malamba R, Shani D, Chitani A, Mallewa JE, Meghji JZ, Ghany JF, Corbett EL, Gordon SB, Davies GR, Khoo SH, Sloan DJ, Mwandumba HC. McCallum AD, et al. Among authors: pertinez he. Clin Infect Dis. 2022 Oct 29;75(9):1520-1528. doi: 10.1093/cid/ciac228. Clin Infect Dis. 2022. PMID: 35325074 Free PMC article.
45 results